Produktbild: Pharmaceutical Biotechnology
- 12%

Pharmaceutical Biotechnology Fundamentals and Applications

12% sparen

111,99 € UVP 128,39 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.10.2013

Abbildungen

XXI, 240 illus., 222 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Daan J. A. Crommelin + weitere

Verlag

Springer Us

Seitenzahl

544

Maße (L/B/H)

28,5/21,5/3,6 cm

Gewicht

1615 g

Auflage

4th edition 2013

Originaltitel

Pharmaceutical Biotechnology, Fundamentals and Applications, 3rd Edition

Sprache

Englisch

ISBN

978-1-4614-6485-3

Beschreibung

Portrait

DAAN J.A. CROMMELIN is Professor at the Department of Pharmaceutics at Utrecht University. Until December 2011 he was scientific director of the Dutch Top Institute Pharma in Leiden. He is adjunct professor at the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. Dr. Crommelin is co-founder of OctoPlus, a Leiden based company specialized in the development of pharmaceutical product formulations and advanced drug delivery systems. He published over 335 articles and has held leadership positions at the International Pharmaceutical Federation (FIP) and the European Federation for Pharmaceutical Sciences (EUFEPS).

ROBERT D. SINDELAR is currently President, The Providence Health Care Research Institute, Vice President Research and Academic, Providence Health Care (part of the British Columbia public health care system), Professor Faculty of Pharmaceutical Sciences and Associate Dean Research Faculty of Medicine The University of British Columbia (UBC).  He served for 11 years as Dean and Professor, The UBC Faculty of Pharmaceutical Sciences following 19 years at the University of Mississippi where he held the positions of Professor and Chair of Medicinal Chemistry, School of Pharmacy and served as Interim Dean.  Dr. Sindelar’s expertise lies in medicinal chemistry, computer-aided drug discovery and design, pharmaceutical biotechnology, and creating opportunities to integrate innovation into the health care system. 

BERND MEIBOHM is Professor of Pharmaceutical Sciences and Associate Dean for Research and Graduate Programs at the University of Tennessee College of Pharmacy in Memphis. His area of expertise lies in clinical pharmacology and pharmacokinetic/pharmacodynamics correlations. Dr. Meibohm obtained his doctoral degree in Pharmaceutics from the Technical University Carolo-Wilhelmina, Braunschweig, Germany and received postdoctoral training at the University of Florida,Gainesville. Dr. Meibohm is a fellow of the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology, and has published three textbooks, more than 90 peer-reviewed research articles and book chapters, 130 abstracts, and over 100 invited scientific presentations to national and international audiences.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.10.2013

Abbildungen

XXI, 240 illus., 222 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Verlag

Springer Us

Seitenzahl

544

Maße (L/B/H)

28,5/21,5/3,6 cm

Gewicht

1615 g

Auflage

4th edition 2013

Originaltitel

Pharmaceutical Biotechnology, Fundamentals and Applications, 3rd Edition

Sprache

Englisch

ISBN

978-1-4614-6485-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Pharmaceutical Biotechnology
  • Chapter 1: Molecular Biotechnology: From DNA Sequence to Therapeutic Protein
    Chapter 2: Biophysical and Biochemical Analysis of Recombinant Proteins
    Chapter 3: Production and Purification of Recombinant Proteins
    Chapter 4: Formulation of Biotech Products, Including Biopharmaceutical Considerations
    Chapter 5: Pharmacokinetics and Pharmacodynamics of Peptide and Protein Therapeutics
    Chapter 6: Immunogenicity of Therapeutic Proteins
    Chapter 7: Monoclonal Antibodies: From Structure to Therapeutic Application Chapter 8: Genomics, Other “Omic” Technologies, Personalized Medicine, and Additional Biotechnology-Related Techniques

    Chapter 8: Genomics, Other “Omic” Technologies, Personalized Medicine, and Additional Biotechnology-Related Techniques
    Chapter 9: Dispensing Biotechnology Products: Handling, Professional Education, and Product Information
    Chapter 10: Economic Considerations in Medical Biotechnology
    Chapter 11: Regulatory Framework for Biosimilars Chapter 12: Insulin

    Chapter 12: Insulin
    Chapter 13: Follicle-Stimulating Hormone
    Chapter 14: Human Growth Hormone
    Chapter 15: Recombinant Coagulation Factors and Thrombolytic Agents
    Chapter 16: Recombinant Human Deoxyribonuclease I
    Chapter 17: Monoclonal Antibodies in Cancer Chapter 18: Hematopoietic Growth Factors: Focus on Erythropoiesis-Stimulating Agents

    Chapter 18: Hematopoietic Growth Factors: Focus on Erythropoiesis-Stimulating Agents
    Chapter 19: Monoclonal Antibodies in Solid Organ Transplantation
    Chapter 20: Monoclonal Antibodies and Antibody-Based Biotherapeutics in Inflammatory Diseases Chapter 21: Interferons and Interleukins
    Chapter 22: Vaccines 

    Chapter 21: Interferons and Interleukins
    Chapter 22: Vaccines 
    Chapter 23: Oligonucleotides
    Chapter 24: Gene Therapy Chapter 25: Stem Cell Technology

    Chapter 25: Stem Cell Technology